Xinyue Wang, MD

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 255 - Initial Results of the Multicenter Phase II Trial of a Novel Hypofractionated Low-Dose Radiotherapy for Indolent Non-Hodgkin Lymphoma

  Monday, September 30, 2024
  5:30 PM – 5:40 PM ET

• 3454 - Treatment and Survival in Early-Stage MALT Lymphoma: A Retrospective Study of Outcomes at a Single Institution

  Tuesday, October 1, 2024
  4:00 PM – 5:00 PM ET